We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast ...
AstraZeneca PLC 29 April 2024 29 April 2024 Truqap plus Faslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer Recommendation based on...
AstraZeneca PLC 29 April 2024 29 April 2024 Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low...
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire ROCKVILLE, Md., April 25, 2024 ROCKVILLE...
AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and ...
AstraZeneca PLC 25 April 2024 AstraZeneca 25 April 2024 Q1 2024 results Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery Revenue and EPS...
Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC. Shares in Angle were up 24% to ...
Deutsche Bank on Tuesday removed AstraZeneca from its 'sell' list, citing an improved dividend and improved forecasts ...
AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 990 | 8.9722675367 | 11034 | 12256 | 11004 | 3191098 | 11579.2350682 | DE |
4 | 1214 | 11.2303422757 | 10810 | 12256 | 10418 | 2156662 | 11105.0007637 | DE |
12 | 1664 | 16.0617760618 | 10360 | 12256 | 9461 | 2739264 | 10409.4410941 | DE |
26 | 1884 | 18.5798816568 | 10140 | 12256 | 9461 | 2399500 | 10391.9930227 | DE |
52 | 298 | 2.54136107795 | 11726 | 12256 | 9461 | 2147314 | 10670.4535851 | DE |
156 | 4530 | 60.4483586869 | 7494 | 12390 | 7392 | 2239739 | 10001.6995797 | DE |
260 | 6181 | 105.784699641 | 5843 | 12390 | 5626 | 2275026 | 8967.25352962 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions